Esperion Therapeutics Ownership 2024 | Who Owns Esperion Therapeutics Now?
Institutional Ownership
80.78%
Insider Ownership
0.50%
Retail Ownership
18.72%
Institutional Holders
190.00
Esperion Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 9.96% | 0.20% | 16,862,943 | 7,733,296 | 84.71% | 37,435,733 | Jun 30, 2024 |
| BLACKROCK INC. | 8.26% | 0.00% | 13,983,662 | 11,144,842 | 392.59% | 31,043,730 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.39% | 0.00% | 10,816,762 | 1,990,216 | 22.55% | 24,013,212 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.88% | 0.36% | 9,944,064 | - | - | 22,075,822 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.85% | 0.01% | 6,513,932 | 832,188 | 14.65% | 14,460,929 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.42% | 2.46% | 5,791,594 | -2,208,406 | -27.61% | 12,857,339 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 3.39% | 2.07% | 5,735,660 | 1,570,003 | 37.69% | 12,733,165 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.98% | 0.11% | 5,049,808 | -2,872,421 | -36.26% | 11,210,574 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.54% | 0.01% | 4,303,596 | 2,087,635 | 94.21% | 9,553,986 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.46% | 0.00% | 4,159,705 | 2,406,512 | 137.26% | 9,236,159 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 2.41% | 0.02% | 4,074,961 | 99,401 | 2.50% | 9,046,413 | Jun 30, 2024 |
| MEDITOR GROUP LTD | 2.24% | 15.57% | 3,791,300 | - | - | 8,416,686 | Jun 30, 2024 |
| STATE STREET CORP | 2.22% | 0.00% | 3,754,512 | 3,203,263 | 581.09% | 8,335,017,000 | Jun 30, 2024 |
| MORGAN STANLEY | 1.97% | 0.00% | 3,328,854 | 1,686,494 | 102.69% | 7,390,055 | Jun 30, 2024 |
| WHITEFORT CAPITAL MANAGEMENT, LP | 1.36% | 3.15% | 2,299,121 | 2,299,121 | 100.00% | 5,104,049 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.34% | 0.00% | 2,272,628 | 2,272,628 | 100.00% | 5,045,234 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.21% | 0.00% | 2,049,529 | -35,572 | -1.71% | 4,549,955 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.17% | 0.42% | 1,975,000 | 1,975,000 | 100.00% | 4,384,500 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.93% | 0.22% | 1,569,459 | 1,569,459 | 100.00% | 3,484,199 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.91% | 0.00% | 1,532,123 | 1,532,123 | 100.00% | 3,401,313 | Jun 30, 2024 |
Esperion Therapeutics's largest institutional shareholder is WASATCH ADVISORS LP, holding 9.96% of the company's total share outstanding, currently valued at $37.44M. The top 10 institutional shareholders own together 49.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MEDITOR GROUP LTD | 2.24% | 15.57% | 3,791,300 | - | - | 8,416,686 | Jun 30, 2024 |
| WHITEFORT CAPITAL MANAGEMENT, LP | 1.36% | 3.15% | 2,299,121 | 2,299,121 | 100.00% | 5,104,049 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.42% | 2.46% | 5,791,594 | -2,208,406 | -27.61% | 12,857,339 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 3.39% | 2.07% | 5,735,660 | 1,570,003 | 37.69% | 12,733,165 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.44% | 0.90% | 743,842 | 667,058 | 868.75% | 1,651,329 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.17% | 0.42% | 1,975,000 | 1,975,000 | 100.00% | 4,384,500 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 5.88% | 0.36% | 9,944,064 | - | - | 22,075,822 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.68% | 0.34% | 1,144,646 | 1,749 | 0.15% | 2,541,114 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.93% | 0.22% | 1,569,459 | 1,569,459 | 100.00% | 3,484,199 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 9.96% | 0.20% | 16,862,943 | 7,733,296 | 84.71% | 37,435,733 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.48% | 0.13% | 813,399 | 364,270 | 81.11% | 1,806,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.07% | 0.12% | 113,178 | 113,178 | 100.00% | 251,255 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.11% | 42,161 | 42,161 | 100.00% | 93,597 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.71% | 0.11% | 1,196,526 | -401,016 | -25.10% | 2,656,288 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.98% | 0.11% | 5,049,808 | -2,872,421 | -36.26% | 11,210,574 | Jun 30, 2024 |
| STONERIDGE INVESTMENT PARTNERS LLC | 0.07% | 0.10% | 117,958 | 24,557 | 26.29% | 262,000 | Jun 30, 2024 |
| INSPIRE INVESTING, LLC | 0.20% | 0.09% | 341,223 | 341,223 | 100.00% | 757,515 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.11% | 0.07% | 183,922 | 183,922 | 100.00% | 408,307 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.22% | 0.07% | 364,681 | 321,859 | 751.62% | 809,592 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.16% | 0.07% | 276,260 | 276,260 | 100.00% | 613,297 | Jun 30, 2024 |
The largest Esperion Therapeutics shareholder by % of total assets is MEDITOR GROUP LTD. The company owns 3.79M shares of Esperion Therapeutics (ESPR), representing 15.57% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 8.26% | 0.00% | 13,983,662 | 11,144,842 | 392.59% | 31,043,730 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 9.96% | 0.20% | 16,862,943 | 7,733,296 | 84.71% | 37,435,733 | Jun 30, 2024 |
| STATE STREET CORP | 2.22% | 0.00% | 3,754,512 | 3,203,263 | 581.09% | 8,335,017,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.46% | 0.00% | 4,159,705 | 2,406,512 | 137.26% | 9,236,159 | Jun 30, 2024 |
| WHITEFORT CAPITAL MANAGEMENT, LP | 1.36% | 3.15% | 2,299,121 | 2,299,121 | 100.00% | 5,104,049 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.34% | 0.00% | 2,272,628 | 2,272,628 | 100.00% | 5,045,234 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.54% | 0.01% | 4,303,596 | 2,087,635 | 94.21% | 9,553,986 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.39% | 0.00% | 10,816,762 | 1,990,216 | 22.55% | 24,013,212 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.17% | 0.42% | 1,975,000 | 1,975,000 | 100.00% | 4,384,500 | Jun 30, 2024 |
| MORGAN STANLEY | 1.97% | 0.00% | 3,328,854 | 1,686,494 | 102.69% | 7,390,055 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 3.39% | 2.07% | 5,735,660 | 1,570,003 | 37.69% | 12,733,165 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.93% | 0.22% | 1,569,459 | 1,569,459 | 100.00% | 3,484,199 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.91% | 0.00% | 1,532,123 | 1,532,123 | 100.00% | 3,401,313 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.85% | 0.01% | 6,513,932 | 832,188 | 14.65% | 14,460,929 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.44% | 0.90% | 743,842 | 667,058 | 868.75% | 1,651,329 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.34% | 0.00% | 572,323 | 555,382 | 3278.33% | 1,270,556 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | 0.00% | 554,914 | 496,923 | 856.90% | 1,231,909 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.25% | 0.00% | 415,900 | 415,900 | 100.00% | 923,298 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.25% | 0.00% | 429,852 | 378,952 | 744.50% | 958,570 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.48% | 0.13% | 813,399 | 364,270 | 81.11% | 1,806,000 | Jun 30, 2024 |
As of Jun 30 2024, Esperion Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 11.14M stocks of ESPR, valued at $31.04M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -13,708,731 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.23% | 0.00% | 382,488 | -4,760,998 | -92.56% | 849,123 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.69% | 0.00% | 1,163,424 | -3,381,836 | -74.40% | 2,582,801 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.98% | 0.11% | 5,049,808 | -2,872,421 | -36.26% | 11,210,574 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.54% | 0.00% | 916,011 | -2,448,255 | -72.77% | 2,033,544 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.42% | 2.46% | 5,791,594 | -2,208,406 | -27.61% | 12,857,339 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.84% | 0.01% | 1,421,900 | -694,600 | -32.82% | 3,156,618 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.65% | 0.00% | 1,102,648 | -504,664 | -31.40% | 2,447,879 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -442,030 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -440,770 | -100.00% | - | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.71% | 0.11% | 1,196,526 | -401,016 | -25.10% | 2,656,288 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -300,300 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -273,292 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -227,630 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -166,457 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -159,038 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -142,418 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.02% | 0.01% | 31,070 | -139,430 | -81.78% | 68,976 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -114,371 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.35% | 0.01% | 595,016 | -109,081 | -15.49% | 1,320,936 | Jun 30, 2024 |
As of Jun 30 2024, Esperion Therapeutics's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -13.71M shares of ESPR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NUVEEN ASSET MANAGEMENT, LLC | 1.34% | 0.00% | 2,272,628 | 2,272,628 | 100.00% | 5,045,234 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.17% | 0.42% | 1,975,000 | 1,975,000 | 100.00% | 4,384,500 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.93% | 0.22% | 1,569,459 | 1,569,459 | 100.00% | 3,484,199 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.91% | 0.00% | 1,532,123 | 1,532,123 | 100.00% | 3,401,313 | Jun 30, 2024 |
| INSPIRE INVESTING, LLC | 0.20% | 0.09% | 341,223 | 341,223 | 100.00% | 757,515 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.11% | 0.07% | 183,922 | 183,922 | 100.00% | 408,307 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 0.11% | 0.00% | 182,500 | 182,500 | 100.00% | 405,150 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.11% | 0.00% | 182,110 | 182,110 | 100.00% | 404,284 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.11% | 0.01% | 181,290 | 181,290 | 100.00% | 402,464 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.07% | 0.12% | 113,178 | 113,178 | 100.00% | 251,255 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 101,658 | 101,658 | 100.00% | 226,697 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.06% | 0.00% | 100,000 | 100,000 | 100.00% | 222,000 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.05% | 0.00% | 91,844 | 91,844 | 100.00% | 203,000 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 76,500 | 76,500 | 100.00% | 170,000 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.04% | 0.00% | 71,488 | 71,488 | 100.00% | 158,703 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.04% | 0.00% | 66,588 | 66,588 | 100.00% | 147,825 | Jun 30, 2024 |
| STATE OF WYOMING | 0.04% | 0.02% | 65,716 | 65,716 | 100.00% | 145,890 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 63,029 | 63,029 | 100.00% | 139,924 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.04% | 0.01% | 60,216 | 60,216 | 100.00% | 131,530 | Jun 30, 2024 |
| MIDLAND WEALTH ADVISORS LLC | 0.04% | 0.01% | 60,000 | 60,000 | 100.00% | 133,200 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 48,316 | 48,316 | 100.00% | 107,262 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.11% | 42,161 | 42,161 | 100.00% | 93,597 | Jun 30, 2024 |
| DAVENPORT & CO LLC | 0.02% | 0.00% | 30,000 | 30,000 | 100.00% | 66,600 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.02% | 0.00% | 28,700 | 28,700 | 100.00% | 63,714 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | 0.02% | 0.03% | 27,374 | 27,374 | 100.00% | 60,770 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.01% | - | 22,518 | 22,518 | 100.00% | 49,990 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.01% | - | 20,500 | 20,500 | 100.00% | 45,510 | Jun 30, 2024 |
| SIVIA CAPITAL PARTNERS, LLC | 0.01% | 0.03% | 20,000 | 20,000 | 100.00% | 44,400 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 18,512 | 18,512 | 100.00% | 41,097 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.01% | - | 17,548 | 17,548 | 100.00% | 38,957 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 17,541 | 17,541 | 100.00% | 38,678 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.00% | 17,007 | 17,007 | 100.00% | 38,000 | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 15,271 | 15,271 | 100.00% | 33,902 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 13,692 | 13,692 | 100.00% | 30,396 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 0.01% | 0.00% | 13,550 | 13,550 | 100.00% | 30,000 | Jun 30, 2024 |
| XPONANCE, INC. | 0.01% | 0.00% | 12,445 | 12,445 | 100.00% | 27,628 | Jun 30, 2024 |
| SIGMA PLANNING CORP | 0.01% | 0.00% | 12,141 | 12,141 | 100.00% | 26,953 | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | 0.01% | 0.00% | 12,047 | 12,047 | 100.00% | 27,000 | Jun 30, 2024 |
| BOKF, NA | 0.01% | 0.00% | 11,905 | 11,905 | 100.00% | 26,429 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.01% | - | 11,694 | 11,694 | 100.00% | 25,000 | Jun 30, 2024 |
| BAXTER BROS INC | 0.01% | 0.00% | 11,000 | 11,000 | 100.00% | 24,420 | Jun 30, 2024 |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 22,200 | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | 0.00% | 0.00% | 7,150 | 7,150 | 100.00% | 15,873 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 6,538 | 6,538 | 100.00% | 15,000 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.00% | - | 3,000 | 3,000 | 100.00% | 6,690 | Jun 30, 2024 |
| HOERTKORN RICHARD CHARLES | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 4,440 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00% | - | 1,000 | 1,000 | 100.00% | 2,220 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 450 | 450 | 100.00% | 999 | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | 0.00% | 0.00% | 435 | 435 | 100.00% | 966 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 342 | 342 | 100.00% | 759 | Jun 30, 2024 |
| BROWN, LISLE/CUMMINGS, INC. | 0.00% | 0.00% | 190 | 190 | 100.00% | 422 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 60 | 60 | 100.00% | 133 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | - | - | 39 | 39 | 100.00% | 87 | Jun 30, 2024 |
Esperion Therapeutics's largest new institutional shareholder by number of shares is NUVEEN ASSET MANAGEMENT, LLC, purchased 2.27M shares, valued at $5.05M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -13,708,731 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -442,030 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -440,770 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -300,300 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -273,292 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -227,630 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -166,457 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -159,038 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -142,418 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -114,371 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -107,900 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -92,300 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -84,367 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -69,025 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -63,500 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -51,200 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -43,214 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -41,000 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -38,762 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -37,100 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -32,173 | -100.00% | - | Jun 30, 2024 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -23,330 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -18,471 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -18,267 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -13,974 | -100.00% | - | Jun 30, 2024 |
| CVI HOLDINGS, LLC | - | - | - | -13,734 | -100.00% | - | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -9,215 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| DEEPCURRENTS INVESTMENT GROUP LLC | - | - | - | -890 | -100.00% | - | Jun 30, 2024 |
| ASSETMARK, INC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
Esperion Therapeutics's largest sold out institutional shareholder by shares sold is ORBIMED ADVISORS LLC, sold -13.71M shares, valued at -, as of undefined.
Esperion Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Jacob Funds Inc. | 1.27% | 291,012 | 211,012 | 263.76% | Feb 29, 2024 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.14% | 900,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.97% | 1,360,000 | - | - | Dec 29, 2023 |
| BANCROFT FUND LTD | 0.89% | 1,240,000 | - | - | Dec 29, 2023 |
| TETON WESTWOOD FUNDS | 0.77% | 500,000 | - | - | Dec 29, 2023 |
| WASATCH FUNDS TRUST | 0.72% | 6,661,467 | 139,474 | 2.14% | Mar 31, 2024 |
| Manager Directed Portfolios | 0.57% | 93,681 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.13% | 68,175 | - | - | Mar 31, 2024 |
| Vanguard Montgomery Funds | 0.12% | 28,875 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.07% | 1,609 | - | - | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.05% | 253,214 | - | - | Jan 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.05% | 373,500 | - | - | Mar 31, 2024 |
| TOCQUEVILLE TRUST | 0.04% | 5,500 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 445,798 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.03% | 14,732 | - | - | Mar 31, 2024 |
| PIONEER SERIES TRUST II | 0.03% | 357,352 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.03% | 26,244 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.02% | 133,227 | - | - | Aug 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,578 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 119,831 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 7,900,105 | 2,110,451 | 36.45% | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 37,000 | - | - | Mar 28, 2024 |
| ETFis Series Trust I | 0.01% | 17,773 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,721 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 7,348 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 133,227 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 17,230 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 12,180 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 20,538 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,110,290 | 71,634 | 6.90% | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 103,744 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 22,771 | - | - | Mar 31, 2024 |
| Destra Investment Trust | 0.00% | 6,740 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 2,178 | 1,182 | 118.67% | Sep 30, 2020 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 8,782 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 193,215 | -89,690 | -31.70% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 30,494 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 106,732 | 48,792 | 84.21% | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 18,932 | - | - | Mar 31, 2020 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 278,152 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 9,775 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 34,003 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 19,996 | - | - | Dec 31, 2023 |
| Voya INVESTORS TRUST | 0.00% | 139,124 | -10,310 | -6.90% | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,764 | - | - | Sep 30, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 29,151 | -4,482 | -13.33% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,765 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 127,197 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 46,375 | -2,577 | -5.26% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 7,855 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 71,898 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 695 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 57,991 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 28,043 | - | - | Mar 31, 2024 |
| PIONEER VARIABLE CONTRACTS TRUST /MA/ | 0.00% | 19,765 | - | - | Mar 28, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 13,341 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 634,031 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 6,030 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,500 | - | - | Mar 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,946 | -38,855 | -86.73% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 1,053 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,081 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 213 | - | - | Apr 30, 2021 |
| ALLSPRING MASTER TRUST | 0.00% | 24,459 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 42,500 | 17,500 | 70.00% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 20,600 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 76,304 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 94,144 | - | - | Jan 31, 2024 |
| Tekla Healthcare Opportunities Fund | 0.00% | 601 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 1,282 | - | - | Mar 28, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 200 | - | - | Dec 31, 2023 |
| NEW COVENANT FUNDS | 0.00% | 962 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 125,226 | - | - | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 4,046 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 190,093 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 22,450 | 21,819 | 3457.84% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 649,003 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,412 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 13,528 | - | - | Mar 31, 2024 |
| PACIFIC FUNDS SERIES TRUST | 0.00% | 42,530 | - | - | Mar 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 574 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 261,955 | - | - | Feb 29, 2024 |
| Meeder Funds | 0.00% | 580 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 33,106 | -1,694 | -4.87% | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 41,683 | - | - | Feb 29, 2024 |
| Tidal ETF Trust | 0.00% | 1,355 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 27,144 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 13,287 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 10,981 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 24,832 | 2,337 | 10.39% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,300 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 10,976 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 293 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 5,481 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 210,079 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 272 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 15,094 | 3,454 | 29.67% | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 2,913 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 323 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 310 | - | - | Feb 29, 2024 |
Esperion Therapeutics's largest mutual fund holder by % of total assets is "Jacob Funds Inc.", owning 291.01K shares, compromising 1.27% of its total assets.
Esperion Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 190 | 13.10% |
| 31 Mar, 24 | 168 | 15.86% |
| 31 Dec, 23 | 145 | 8.21% |
| 30 Sep, 23 | 134 | -2.19% |
| 30 Jun, 23 | 137 | -25.14% |
| 31 Mar, 23 | 183 | -2.66% |
| 31 Dec, 22 | 188 | 17.50% |
| 30 Sep, 22 | 160 | 10.34% |
| 30 Jun, 22 | 145 | 5.84% |
| 31 Mar, 22 | 137 | -4.20% |
| 31 Dec, 21 | 143 | -6.54% |
| 30 Sep, 21 | 153 | 0.66% |
| 30 Jun, 21 | 152 | -10.59% |
| 31 Mar, 21 | 170 | 2.41% |
| 31 Dec, 20 | 166 | -7.26% |
| 30 Sep, 20 | 179 | -13.94% |
| 30 Jun, 20 | 208 | 11.83% |
| 31 Mar, 20 | 186 | -6.06% |
| 31 Dec, 19 | 198 | 17.16% |
| 30 Sep, 19 | 169 | -11.05% |
| 30 Jun, 19 | 190 | 5.56% |
| 31 Mar, 19 | 180 | 2.86% |
| 31 Dec, 18 | 175 | -2.23% |
| 30 Sep, 18 | 179 | 1.13% |
| 30 Jun, 18 | 177 | -16.51% |
| 31 Mar, 18 | 212 | 15.22% |
| 31 Dec, 17 | 184 | 6.98% |
| 30 Sep, 17 | 172 | 10.26% |
| 30 Jun, 17 | 156 | 12.23% |
| 31 Mar, 17 | 139 | 28.70% |
| 31 Dec, 16 | 108 | -5.26% |
| 30 Sep, 16 | 114 | 3.64% |
| 30 Jun, 16 | 110 | -8.33% |
| 31 Mar, 16 | 120 | -3.23% |
| 31 Dec, 15 | 124 | -7.46% |
| 30 Sep, 15 | 134 | -21.64% |
| 30 Jun, 15 | 171 | 11.04% |
| 31 Mar, 15 | 154 | 77.01% |
| 31 Dec, 14 | 87 | 74.00% |
| 30 Sep, 14 | 50 | 16.28% |
| 30 Jun, 14 | 43 | 7.50% |
| 31 Mar, 14 | 40 | -9.09% |
| 31 Dec, 13 | 44 | - |
| 30 Sep, 13 | 44 | 780.00% |
| 30 Jun, 13 | 5 | - |
| 30 Jun, 10 | 1 | - |
As of 30 Jun 24, 190 institutions are holding Esperion Therapeutics's shares, representing an increase of 13.10% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 136,727,396 | 9.13% |
| 31 Mar, 24 | 125,288,686 | 74.81% |
| 31 Dec, 23 | 71,670,941 | -7.32% |
| 30 Sep, 23 | 77,332,889 | 3.99% |
| 30 Jun, 23 | 74,368,075 | -8.15% |
| 31 Mar, 23 | 80,968,056 | 10.20% |
| 31 Dec, 22 | 73,471,726 | 16.03% |
| 30 Sep, 22 | 63,319,231 | 14.36% |
| 30 Jun, 22 | 55,368,725 | 7.08% |
| 31 Mar, 22 | 51,707,546 | -0.57% |
| 31 Dec, 21 | 52,006,237 | 111.21% |
| 30 Sep, 21 | 24,623,002 | -12.29% |
| 30 Jun, 21 | 28,072,631 | -1.44% |
| 31 Mar, 21 | 28,481,705 | -7.77% |
| 31 Dec, 20 | 30,882,506 | -2.40% |
| 30 Sep, 20 | 31,643,169 | -1.03% |
| 30 Jun, 20 | 31,971,481 | 7.28% |
| 31 Mar, 20 | 29,802,226 | 7.02% |
| 31 Dec, 19 | 27,847,902 | 3.03% |
| 30 Sep, 19 | 27,028,398 | -46.39% |
| 30 Jun, 19 | 50,413,112 | 82.73% |
| 31 Mar, 19 | 27,588,967 | 2.90% |
| 31 Dec, 18 | 26,812,165 | -5.31% |
| 30 Sep, 18 | 28,315,854 | -8.26% |
| 30 Jun, 18 | 30,866,135 | 16.43% |
| 31 Mar, 18 | 26,510,628 | 9.10% |
| 31 Dec, 17 | 24,300,393 | 0.59% |
| 30 Sep, 17 | 24,158,104 | 14.71% |
| 30 Jun, 17 | 21,060,103 | 17.11% |
| 31 Mar, 17 | 17,982,876 | 21.34% |
| 31 Dec, 16 | 14,820,685 | 2.67% |
| 30 Sep, 16 | 14,435,610 | -1.96% |
| 30 Jun, 16 | 14,724,329 | -7.15% |
| 31 Mar, 16 | 15,858,476 | -3.46% |
| 31 Dec, 15 | 16,427,223 | -35.05% |
| 30 Sep, 15 | 25,292,374 | 49.32% |
| 30 Jun, 15 | 16,937,808 | 13.76% |
| 31 Mar, 15 | 14,888,978 | 51.40% |
| 31 Dec, 14 | 9,833,983 | 76.99% |
| 30 Sep, 14 | 5,556,097 | -0.00% |
| 30 Jun, 14 | 5,556,321 | 61.95% |
| 31 Mar, 14 | 3,430,908 | 1.01% |
| 31 Dec, 13 | 3,396,474 | -0.04% |
| 30 Sep, 13 | 3,397,864 | 298.01% |
| 30 Jun, 13 | 853,708 | - |
| 30 Jun, 10 | 2,100 | - |
Esperion Therapeutics (ESPR) has 136.73M shares outstanding as of 30 Jun 24, up 9.13% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 80.78% | 0.65% |
| 31 Mar, 24 | 111.46% | 2.72% |
| 31 Dec, 23 | 64.07% | 1.28% |
| 30 Sep, 23 | 70.79% | 0.79% |
| 30 Jun, 23 | 94.81% | 0.89% |
| 31 Mar, 23 | 103.22% | 0.84% |
| 31 Dec, 22 | 110.64% | 1.27% |
| 30 Sep, 22 | 93.38% | 1.22% |
| 30 Jun, 22 | 87.57% | 1.22% |
| 31 Mar, 22 | 84.83% | 0.43% |
| 31 Dec, 21 | 141.15% | 1.63% |
| 30 Sep, 21 | 93.07% | 0.81% |
| 30 Jun, 21 | 107.05% | 0.89% |
| 31 Mar, 21 | 109.58% | 0.87% |
| 31 Dec, 20 | 112.41% | 0.87% |
| 30 Sep, 20 | 113.70% | 0.85% |
| 30 Jun, 20 | 115.56% | 0.99% |
| 31 Mar, 20 | 108.30% | 1.02% |
| 31 Dec, 19 | 102.80% | 1.04% |
| 30 Sep, 19 | 99.47% | 0.28% |
| 30 Jun, 19 | 186.93% | 1.77% |
| 31 Mar, 19 | 102.78% | 1.02% |
| 31 Dec, 18 | 100.22% | 0.90% |
| 30 Sep, 18 | 105.64% | 0.80% |
| 30 Jun, 18 | 115.23% | 1.16% |
| 31 Mar, 18 | 99.64% | 1.16% |
| 31 Dec, 17 | 92.67% | 0.94% |
| 30 Sep, 17 | 99.37% | 1.14% |
| 30 Jun, 17 | 93.22% | 1.47% |
| 31 Mar, 17 | 79.70% | 1.85% |
| 31 Dec, 16 | 65.71% | 1.60% |
| 30 Sep, 16 | 64.01% | 1.50% |
| 30 Jun, 16 | 65.32% | 1.32% |
| 31 Mar, 16 | 70.38% | 1.26% |
| 31 Dec, 15 | 74.60% | 0.59% |
| 30 Sep, 15 | 112.44% | 1.98% |
| 30 Jun, 15 | 75.40% | 1.44% |
| 31 Mar, 15 | 72.31% | 2.00% |
| 31 Dec, 14 | 60.06% | 4.63% |
| 30 Sep, 14 | 36.00% | 2.77% |
| 30 Jun, 14 | 36.08% | 7.24% |
| 31 Mar, 14 | 22.32% | 1.20% |
| 31 Dec, 13 | 43.07% | 2.32% |
| 30 Sep, 13 | 43.09% | 36.77% |
| 30 Jun, 13 | 10.83% | - |
| 30 Jun, 10 | 0.03% | - |
As of 30 Jun 24, Esperion Therapeutics is held by 80.78% institutional shareholders, representing a 0.65% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 108 | 11.34% |
| 31 Mar, 24 | 97 | 51.56% |
| 31 Dec, 23 | 64 | 10.34% |
| 30 Sep, 23 | 58 | 7.41% |
| 30 Jun, 23 | 54 | -44.33% |
| 31 Mar, 23 | 97 | -9.35% |
| 31 Dec, 22 | 107 | 33.75% |
| 30 Sep, 22 | 80 | 19.40% |
| 30 Jun, 22 | 67 | -12.99% |
| 31 Mar, 22 | 77 | -7.23% |
| 31 Dec, 21 | 83 | 40.68% |
| 30 Sep, 21 | 59 | - |
| 30 Jun, 21 | 59 | -11.94% |
| 31 Mar, 21 | 67 | -4.29% |
| 31 Dec, 20 | 70 | 1.45% |
| 30 Sep, 20 | 69 | -38.94% |
| 30 Jun, 20 | 113 | 31.40% |
| 31 Mar, 20 | 86 | -14.00% |
| 31 Dec, 19 | 100 | 56.25% |
| 30 Sep, 19 | 64 | -31.18% |
| 30 Jun, 19 | 93 | 2.20% |
| 31 Mar, 19 | 91 | 30.00% |
| 31 Dec, 18 | 70 | -10.26% |
| 30 Sep, 18 | 78 | -15.22% |
| 30 Jun, 18 | 92 | -17.12% |
| 31 Mar, 18 | 111 | 23.33% |
| 31 Dec, 17 | 90 | 1.12% |
| 30 Sep, 17 | 89 | 30.88% |
| 30 Jun, 17 | 68 | -12.82% |
| 31 Mar, 17 | 78 | 69.57% |
| 31 Dec, 16 | 46 | 4.55% |
| 30 Sep, 16 | 44 | -16.98% |
| 30 Jun, 16 | 53 | -8.62% |
| 31 Mar, 16 | 58 | - |
| 31 Dec, 15 | 58 | -25.64% |
| 30 Sep, 15 | 78 | -33.90% |
| 30 Jun, 15 | 118 | 7.27% |
| 31 Mar, 15 | 110 | 66.67% |
| 31 Dec, 14 | 66 | 153.85% |
| 30 Sep, 14 | 26 | 13.04% |
| 30 Jun, 14 | 23 | 15.00% |
| 31 Mar, 14 | 20 | -20.00% |
| 31 Dec, 13 | 25 | -40.48% |
| 30 Sep, 13 | 42 | 740.00% |
| 30 Jun, 13 | 5 | - |
| 30 Jun, 10 | 1 | - |
108 institutional shareholders have increased their position in ESPR stock as of 30 Jun 24 compared to 97 in the previous quarter (a 11.34% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | 7.69% |
| 31 Mar, 24 | 26 | -35.00% |
| 31 Dec, 23 | 40 | 25.00% |
| 30 Sep, 23 | 32 | -17.95% |
| 30 Jun, 23 | 39 | -18.75% |
| 31 Mar, 23 | 48 | 23.08% |
| 31 Dec, 22 | 39 | -7.14% |
| 30 Sep, 22 | 42 | -6.67% |
| 30 Jun, 22 | 45 | 60.71% |
| 31 Mar, 22 | 28 | - |
| 31 Dec, 21 | 28 | -30.00% |
| 30 Sep, 21 | 40 | -14.89% |
| 30 Jun, 21 | 47 | -14.55% |
| 31 Mar, 21 | 55 | 7.84% |
| 31 Dec, 20 | 51 | -13.56% |
| 30 Sep, 20 | 59 | 63.89% |
| 30 Jun, 20 | 36 | -33.33% |
| 31 Mar, 20 | 54 | 22.73% |
| 31 Dec, 19 | 44 | -4.35% |
| 30 Sep, 19 | 46 | 6.98% |
| 30 Jun, 19 | 43 | 2.38% |
| 31 Mar, 19 | 42 | -28.81% |
| 31 Dec, 18 | 59 | 20.41% |
| 30 Sep, 18 | 49 | 4.26% |
| 30 Jun, 18 | 47 | -14.55% |
| 31 Mar, 18 | 55 | - |
| 31 Dec, 17 | 55 | 22.22% |
| 30 Sep, 17 | 45 | -15.09% |
| 30 Jun, 17 | 53 | 76.67% |
| 31 Mar, 17 | 30 | - |
| 31 Dec, 16 | 30 | - |
| 30 Sep, 16 | 30 | - |
| 30 Jun, 16 | 30 | 15.38% |
| 31 Mar, 16 | 26 | -18.75% |
| 31 Dec, 15 | 32 | - |
| 30 Sep, 15 | 32 | 18.52% |
| 30 Jun, 15 | 27 | - |
| 31 Mar, 15 | 27 | 125.00% |
| 31 Dec, 14 | 12 | -20.00% |
| 30 Sep, 14 | 15 | -6.25% |
| 30 Jun, 14 | 16 | 14.29% |
| 31 Mar, 14 | 14 | -12.50% |
| 31 Dec, 13 | 16 | 700.00% |
| 30 Sep, 13 | 2 | - |
| 30 Jun, 13 | - | - |
| 30 Jun, 10 | - | - |
28 institutional shareholders have reduced their position in ESPR stock as of 30 Jun 24 compared to 26 in the previous quarter (a 7.69% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 190 | 13.10% | 136,727,396 | 9.13% | 80.78% | 0.65% | 108 | 11.34% | 28 | 7.69% |
| 31 Mar, 24 | 168 | 15.86% | 125,288,686 | 74.81% | 111.46% | 2.72% | 97 | 51.56% | 26 | -35.00% |
| 31 Dec, 23 | 145 | 8.21% | 71,670,941 | -7.32% | 64.07% | 1.28% | 64 | 10.34% | 40 | 25.00% |
| 30 Sep, 23 | 134 | -2.19% | 77,332,889 | 3.99% | 70.79% | 0.79% | 58 | 7.41% | 32 | -17.95% |
| 30 Jun, 23 | 137 | -25.14% | 74,368,075 | -8.15% | 94.81% | 0.89% | 54 | -44.33% | 39 | -18.75% |
| 31 Mar, 23 | 183 | -2.66% | 80,968,056 | 10.20% | 103.22% | 0.84% | 97 | -9.35% | 48 | 23.08% |
| 31 Dec, 22 | 188 | 17.50% | 73,471,726 | 16.03% | 110.64% | 1.27% | 107 | 33.75% | 39 | -7.14% |
| 30 Sep, 22 | 160 | 10.34% | 63,319,231 | 14.36% | 93.38% | 1.22% | 80 | 19.40% | 42 | -6.67% |
| 30 Jun, 22 | 145 | 5.84% | 55,368,725 | 7.08% | 87.57% | 1.22% | 67 | -12.99% | 45 | 60.71% |
| 31 Mar, 22 | 137 | -4.20% | 51,707,546 | -0.57% | 84.83% | 0.43% | 77 | -7.23% | 28 | - |
| 31 Dec, 21 | 143 | -6.54% | 52,006,237 | 111.21% | 141.15% | 1.63% | 83 | 40.68% | 28 | -30.00% |
| 30 Sep, 21 | 153 | 0.66% | 24,623,002 | -12.29% | 93.07% | 0.81% | 59 | - | 40 | -14.89% |
| 30 Jun, 21 | 152 | -10.59% | 28,072,631 | -1.44% | 107.05% | 0.89% | 59 | -11.94% | 47 | -14.55% |
| 31 Mar, 21 | 170 | 2.41% | 28,481,705 | -7.77% | 109.58% | 0.87% | 67 | -4.29% | 55 | 7.84% |
| 31 Dec, 20 | 166 | -7.26% | 30,882,506 | -2.40% | 112.41% | 0.87% | 70 | 1.45% | 51 | -13.56% |
| 30 Sep, 20 | 179 | -13.94% | 31,643,169 | -1.03% | 113.70% | 0.85% | 69 | -38.94% | 59 | 63.89% |
| 30 Jun, 20 | 208 | 11.83% | 31,971,481 | 7.28% | 115.56% | 0.99% | 113 | 31.40% | 36 | -33.33% |
| 31 Mar, 20 | 186 | -6.06% | 29,802,226 | 7.02% | 108.30% | 1.02% | 86 | -14.00% | 54 | 22.73% |
| 31 Dec, 19 | 198 | 17.16% | 27,847,902 | 3.03% | 102.80% | 1.04% | 100 | 56.25% | 44 | -4.35% |
| 30 Sep, 19 | 169 | -11.05% | 27,028,398 | -46.39% | 99.47% | 0.28% | 64 | -31.18% | 46 | 6.98% |
| 30 Jun, 19 | 190 | 5.56% | 50,413,112 | 82.73% | 186.93% | 1.77% | 93 | 2.20% | 43 | 2.38% |
| 31 Mar, 19 | 180 | 2.86% | 27,588,967 | 2.90% | 102.78% | 1.02% | 91 | 30.00% | 42 | -28.81% |
| 31 Dec, 18 | 175 | -2.23% | 26,812,165 | -5.31% | 100.22% | 0.90% | 70 | -10.26% | 59 | 20.41% |
| 30 Sep, 18 | 179 | 1.13% | 28,315,854 | -8.26% | 105.64% | 0.80% | 78 | -15.22% | 49 | 4.26% |
| 30 Jun, 18 | 177 | -16.51% | 30,866,135 | 16.43% | 115.23% | 1.16% | 92 | -17.12% | 47 | -14.55% |
| 31 Mar, 18 | 212 | 15.22% | 26,510,628 | 9.10% | 99.64% | 1.16% | 111 | 23.33% | 55 | - |
| 31 Dec, 17 | 184 | 6.98% | 24,300,393 | 0.59% | 92.67% | 0.94% | 90 | 1.12% | 55 | 22.22% |
| 30 Sep, 17 | 172 | 10.26% | 24,158,104 | 14.71% | 99.37% | 1.14% | 89 | 30.88% | 45 | -15.09% |
| 30 Jun, 17 | 156 | 12.23% | 21,060,103 | 17.11% | 93.22% | 1.47% | 68 | -12.82% | 53 | 76.67% |
| 31 Mar, 17 | 139 | 28.70% | 17,982,876 | 21.34% | 79.70% | 1.85% | 78 | 69.57% | 30 | - |
| 31 Dec, 16 | 108 | -5.26% | 14,820,685 | 2.67% | 65.71% | 1.60% | 46 | 4.55% | 30 | - |
| 30 Sep, 16 | 114 | 3.64% | 14,435,610 | -1.96% | 64.01% | 1.50% | 44 | -16.98% | 30 | - |
| 30 Jun, 16 | 110 | -8.33% | 14,724,329 | -7.15% | 65.32% | 1.32% | 53 | -8.62% | 30 | 15.38% |
| 31 Mar, 16 | 120 | -3.23% | 15,858,476 | -3.46% | 70.38% | 1.26% | 58 | - | 26 | -18.75% |
| 31 Dec, 15 | 124 | -7.46% | 16,427,223 | -35.05% | 74.60% | 0.59% | 58 | -25.64% | 32 | - |
| 30 Sep, 15 | 134 | -21.64% | 25,292,374 | 49.32% | 112.44% | 1.98% | 78 | -33.90% | 32 | 18.52% |
| 30 Jun, 15 | 171 | 11.04% | 16,937,808 | 13.76% | 75.40% | 1.44% | 118 | 7.27% | 27 | - |
| 31 Mar, 15 | 154 | 77.01% | 14,888,978 | 51.40% | 72.31% | 2.00% | 110 | 66.67% | 27 | 125.00% |
| 31 Dec, 14 | 87 | 74.00% | 9,833,983 | 76.99% | 60.06% | 4.63% | 66 | 153.85% | 12 | -20.00% |
| 30 Sep, 14 | 50 | 16.28% | 5,556,097 | -0.00% | 36.00% | 2.77% | 26 | 13.04% | 15 | -6.25% |
| 30 Jun, 14 | 43 | 7.50% | 5,556,321 | 61.95% | 36.08% | 7.24% | 23 | 15.00% | 16 | 14.29% |
| 31 Mar, 14 | 40 | -9.09% | 3,430,908 | 1.01% | 22.32% | 1.20% | 20 | -20.00% | 14 | -12.50% |
| 31 Dec, 13 | 44 | - | 3,396,474 | -0.04% | 43.07% | 2.32% | 25 | -40.48% | 16 | 700.00% |
| 30 Sep, 13 | 44 | 780.00% | 3,397,864 | 298.01% | 43.09% | 36.77% | 42 | 740.00% | 2 | - |
| 30 Jun, 13 | 5 | - | 853,708 | - | 10.83% | - | 5 | - | - | - |
| 30 Jun, 10 | 1 | - | 2,100 | - | 0.03% | - | 1 | - | - | - |
Esperion Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Esperion Therapeutics's stock was made by Warren Eric on Jul 19 2024, selling 108 shares at $2.59 per share (valued at $279.40).
Esperion Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | 14 | 3 | 466.67% |
| Q1 2024 | 10 | - | - |
| Q3 2023 | 2 | 3 | 66.67% |
| Q2 2023 | 20 | 5 | 400.00% |
| Q1 2023 | 10 | 8 | 125.00% |
| Q4 2022 | 2 | 3 | 66.67% |
| Q3 2022 | 2 | 5 | 40.00% |
| Q2 2022 | 22 | 3 | 733.33% |
| Q1 2022 | 6 | 4 | 150.00% |
| Q4 2021 | 3 | - | - |
| Q2 2021 | 18 | - | - |
| Q1 2021 | 7 | - | - |
| Q4 2020 | 2 | 1 | 200.00% |
| Q2 2020 | 9 | - | - |
| Q1 2020 | 9 | 10 | 90.00% |
| Q4 2019 | 2 | 2 | 100.00% |
| Q3 2019 | 6 | - | - |
| Q2 2019 | 11 | - | - |
| Q1 2019 | 7 | 4 | 175.00% |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Esperion Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | - | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 4 | 5 | 80.00% |
| Q1 2023 | - | 8 | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | 2 | 5 | 40.00% |
| Q2 2022 | 1 | 3 | 33.33% |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | - | - |
| Q2 2021 | 4 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 3 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 6 | - | - |
| Q2 2019 | 1 | 2 | 50.00% |
| Q1 2019 | 5 | 3 | 166.67% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Esperion Therapeutics's stocks.
Esperion Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ELAN | Elanco Animal Health Incorporated |
| ITCI | Intra-Cellular Therapies, Inc. |
| ANIP | ANI Pharmaceuticals, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| PAHC | Phibro Animal Health Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| PBH | Prestige Consumer Healthcare Inc. |
| RMTI | Rockwell Medical, Inc. |
| AGRX | Agile Therapeutics, Inc. |
| ALKS | Alkermes plc |
| KMDA | Kamada Ltd. |
| PCRX | Pacira BioSciences, Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| CTLT | Catalent, Inc. |
| AVDL | Avadel Pharmaceuticals plc |
| SIGA | SIGA Technologies, Inc. |
| EGRX | Eagle Pharmaceuticals, Inc. |
ESPR Ownership FAQ
Who Owns Esperion Therapeutics?
Esperion Therapeutics is owned by institutional shareholders (80.78%), insiders (0.50%), and public (18.72%). The largest institutional shareholder of Esperion Therapeutics is WASATCH ADVISORS LP (9.96% of total shares) and the top mutual fund owner is Jacob Funds Inc. (1.27% of total shares).
Who are the major institutional shareholders of Esperion Therapeutics?
Esperion Therapeutics's major institutional shareholders are WASATCH ADVISORS LP, BLACKROCK INC., VANGUARD GROUP INC, BELLEVUE GROUP AG, and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 34.34% of the company's share outstanding.
How many Esperion Therapeutics shareholders are there?
As of Jun 2024, there are 190 institutional shareholders of Esperion Therapeutics.
What percentage of Esperion Therapeutics is owned by WASATCH ADVISORS LP?
WASATCH ADVISORS LP owns 16.86M shares of Esperion Therapeutics, representing 9.96% of the company's total shares outstanding, valued at $37.44M (as of Jun 2024).
What percentage of Esperion Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 13.98M shares of Esperion Therapeutics (ESPR), compromising 8.26% of the company, valued at $31.04M.
What percentage of Esperion Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Esperion Therapeutics. The company owns 10.82M of the company's shares outstanding (worth $24.01M).